Several studies have reported that PAK3 is implicated in cognitive impairment in various neurological and psychiatric disorders, including schizophrenia and Alzheimer’s disease (AD) (Lauterborn et al., 2020; Morrow et al., 2008). Here, PAK3 is linked to Cognitive impairment.